Higher Doses of Botulinum Toxin in the Treatment of Gummy Smile

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 20, 2019

Primary Completion Date

August 20, 2020

Study Completion Date

October 20, 2021

Conditions
SmilingBotulinum Toxins, Type A
Interventions
DRUG

injection of Botulinum type A

The participates were allocated to two different application methods: Simplified Method for the first injection and Individualized Method 8 months later. All the patients underwent twice injection with each methods with no change of the BTX-A(Botox, Allergan, Irvine, CA) and other injection details: Lyophilized 100 U of Botox was reconstituted in 2.5 mL of 0.9% sodium chloride solution. The injections were made with a 27-gauge insulin syringe. The treatment was an outpatient procedure and all injections were performed by one of the authors (X.G.). No anesthesia was given during the procedure.

Trial Locations (1)

100010

Peking University School and Hospital of Stomatology, Beijing

All Listed Sponsors
lead

Peking University

OTHER

NCT05127018 - Higher Doses of Botulinum Toxin in the Treatment of Gummy Smile | Biotech Hunter | Biotech Hunter